Genetic Technologies Ltd (GTG.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2014 | 06-2013 | 06-2012 | 06-2011 | 06-2010 | |
| Sales | 4,564 | 3,377 | 3,691 | 18,276 | 9,757 |
| Cost of Goods | 1,838 | 1,945 | 1,949 | 2,035 | 2,717 |
| Gross Profit | 2,727 | 1,432 | 1,743 | 16,241 | 7,040 |
| Operating Expenses | 12,580 | 10,577 | 12,763 | 15,193 | 14,722 |
| Operating Income | -9,853 | -9,145 | -11,020 | 1,047 | -7,682 |
| Interest Expense | 744 | 39 | 45 | 82 | 100 |
| Other Income | 463 | -165 | 5,769 | -64 | 7,782 |
| Pre-tax Income | -10,134 | -9,349 | -5,297 | 901 | N/A |
| Net Income Continuous | -10,134 | -9,349 | -5,297 | 901 | -9,355 |
| Minority Interests | 9 | 51 | 9 | 9 | 11 |
| Net Income | $-10,125 | $-9,298 | $-5,288 | $910 | $-9,344 |
| EPS Basic Total Ops | -1.64 | -1.84 | -1.07 | 0.21 | -2.33 |
| EPS Basic Continuous Ops | -1.64 | -1.84 | -1.07 | 0.21 | -2.33 |
| EPS Diluted Total Ops | -1.64 | -1.84 | -1.07 | 0.21 | -2.33 |
| EPS Diluted Continuous Ops | -1.64 | -1.84 | -1.07 | 0.21 | -2.33 |
| EBITDA(a) | $-9,390 | $-9,311 | $-5,252 | $1,600 | $-3,976 |